Protein homeostasis machinery

Protein homeostasis machinery (also referred to as the proteostasis machinery or network) describes the integrated system of cellular components that maintain the balance of protein synthesis, folding, trafficking, and degradation, ensuring a functional and healthy proteome[1][3][5][7]. The main elements of this network include ribosomes (for synthesis), molecular chaperones (for folding and quality control), the endoplasmic reticulum (for folding and trafficking), and proteolytic complexes such as the proteasome and autophagy pathways (for degradation). This system protects cells from the harmful effects of misfolded or aggregated proteins, especially under stress or aging. Failure of the protein homeostasis machinery is implicated in neurodegenerative diseases, cancers, and the aging process[3][4][7]. Additional details: - Protein homeostasis machinery is not a single molecule, gene, or protein, but rather a broad network of various molecular machines and pathways. It includes but is not limited to ribosomes, proteasomes, heat shock proteins (HSPs), molecular chaperones, autophagy components, and ER-associated machinery[1][2][3][5][7]. - The term is thus too general to refer to a single therapeutic target, receptor, or specific molecular entity suitable for drug targeting or direct clinical biomarker use[1][5][7]. - Dysregulation of this system is common in diseases that involve protein aggregation (such as Alzheimer’s, Parkinson’s, and Huntington’s diseases), many cancers, and cellular aging[3][4][7]. - While small molecules and drugs can modulate components of the protein homeostasis machinery (e.g., HSP90 inhibitors, proteasome inhibitors like bortezomib), these drugs act on discrete proteins within the network, not the network as a whole[6]. Key point: "Protein homeostasis machinery" is not a canonical target, receptor, or enzyme, but a broad cellular system comprised of numerous molecular machines and pathways. Therefore, it is not classified as a therapeutic target in the strict sense, is an incorrect or too-general entry for a single molecular target, and does not fit the molecular, pharmacological, or biomarker categories typically used for drug development[1][3][5][6][7].

Other names

Proteostasis machineryProtein quality control machineryProteostasis network